PADI2 Inhibitors

PADI2 inhibitors, short for Peptidylarginine deiminase 2 inhibitors, belong to a specialized class of chemical compounds designed to target and modulate the activity of the enzyme PADI2, also known as PAD2 (Peptidylarginine deiminase 2). PADI2 is a member of the peptidylarginine deiminase family of enzymes, which play a crucial role in post-translational protein modification. Specifically, PADI2 catalyzes the conversion of arginine residues in proteins to citrulline through a process called citrullination. This enzymatic modification can have significant implications for the structure and function of proteins within the body.

PADI2 inhibitors are designed to interfere with the activity of PADI2 by binding to the enzyme and preventing it from catalyzing citrullination. By inhibiting PADI2, these compounds can potentially influence various cellular processes and signaling pathways that rely on citrullinated proteins. The inhibition of PADI2 may have implications in the context of certain diseases and conditions where abnormal citrullination plays a role.